Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population-Reference-Cited by-同舟云学术

Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population

Published:2023-02-14 Issue:1 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Fernandes-Matano Larissa¹²^ORCID,Salas-Lais Angel Gustavo³^ORCID,Grajales-Muñiz Concepción⁴^ORCID,Hernández-Ávila Mauricio⁵^ORCID,Garfias-Becerra Yonathan Omar⁶⁷^ORCID,Rodríguez-Sepúlveda Mario César⁵^ORCID,Segura-Sánchez Carlos⁵^ORCID,Montes-Herrera Daniel³,Mendoza-Sánchez Denisse³,Angeles-Martínez Javier³^ORCID,Santos Coy-Arechavaleta Andrea³^ORCID,Alvarado-Yaah Julio Elías³^ORCID,Santacruz-Tinoco Clara Esperanza⁸^ORCID,Ramón-Gallegos Eva²^ORCID,Muñoz-Medina José Esteban¹^ORCID

Affiliation:

1. Coordinación de Calidad de Insumos y Laboratorios Especializados, Instuto Mexicano del Seguro Social, Mexico City, Mexico

2. Escuela Nacional de Ciencias Biológicas, Programa de Doctorado en Biomedicina y Biotecnología Molecular, Instituto Politécnico Nacional, Mexico City, Mexico

3. Laboratorio Central de Epidemiología, Instituto Mexicano del Seguro Social, Mexico City, Mexico

4. Oficina de Vigilancia Epidemiológica del Programa IMSS Bienestar, Mexico City, Mexico

5. Dirección de Prestaciones Economicas y Sociales, Instituto Mexicano del Seguro Social, Mexico City, Mexico

6. Research Unit, Institute of Ophthalmology, Conde De Valenciana Foundation, Mexico City, Mexico

7. Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autónoma de México (National Autonomous University of Mexico), Mexico City, Mexico

8. Division de Laboratorios Especializados, Instituto Mexicano del Seguro Social, Mexico City, Mexico

Abstract

Since the start of the vaccination programs against COVID-19 in 2020, it was evident that due to global shortages, the demand for the dose required in Mexico could only be covered by acquiring different vaccines. Therefore, determining the effectiveness of these and the longevity of acquired immunity is extremely important in a scenario where SARS-CoV-2 circulation becomes endemic and booster doses are required periodically.

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02376-22

Reference54 articles.

1. World Health Organization. 2022. WHO coronavirus (COVID-19) dashboard. World Health Organization Geneva Switzerland. https://covid19.who.int.

2. Our World in Data. 2022. Coronavirus (COVID-19) vaccinations. Our World in Data Oxford UK. https://ourworldindata.org/covid-vaccinations.

3. World Health Organization. 2022. Coronavirus disease (COVID-19): vaccines. World Health Organization Geneva Switzerland. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines.

4. World Health Organization. 2022. COVID-19 vaccine tracker and landscape. World Health Organization Geneva Switzerland. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.

5. World Health Organization. 2022. Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. World Health Organization Geneva Switzerland. https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_02April2022.pdf.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Clinical Factors and SARS-CoV-2 Variants on Antibody Production in Vaccinated German Healthcare Professionals Infected Either with the Delta or the Omicron Variant;Vaccines;2024-02-05

2. Association of Obesity with SARS-CoV-2 and Its Relationship with the Humoral Response Prior to Vaccination in the State of Mexico: A Cross-Sectional Study;Diagnostics;2023-08-09

3. Association of Toxoplasmosis and COVID-19 in a Mexican Population;Microorganisms;2023-05-30

4. Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines;Vaccines;2023-03-19